Glass M - Search Results

1

Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.

Dowie MJ, Bradshaw HB, Howard ML, Nicholson LF, Faull RL, Hannan AJ, Glass M. Dowie MJ, et al. Among authors: glass m. Neuroscience. 2009 Sep 29;163(1):456-65. doi: 10.1016/j.neuroscience.2009.06.014. Epub 2009 Jun 10. Neuroscience. 2009. PMID: 19524019

Loss of cannabinoid CB1 receptor ligand binding in key brain regions is detected early in HD in human postmortem tissue [Glass M, Dragunow M, Faull RL (2000) The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamin …

Loss of cannabinoid CB1 receptor ligand binding in key brain regions is detected early in HD in human postmortem tissue [Glass M …

2

Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.

Glass M, Faull RL, Dragunow M. Glass M, et al. Neuroscience. 1993 Oct;56(3):523-7. doi: 10.1016/0306-4522(93)90352-g. Neuroscience. 1993. PMID: 8255419

3

Loss of A1 adenosine receptors in human temporal lobe epilepsy.

Glass M, Faull RL, Bullock JY, Jansen K, Mee EW, Walker EB, Synek BJ, Dragunow M. Glass M, et al. Brain Res. 1996 Feb 26;710(1-2):56-68. doi: 10.1016/0006-8993(95)01313-x. Brain Res. 1996. PMID: 8963679

4

Localisation of the adenosine uptake site in the human brain: a comparison with the distribution of adenosine A1 receptors.

Glass M, Faull RL, Dragunow M. Glass M, et al. Brain Res. 1996 Feb 26;710(1-2):79-91. doi: 10.1016/0006-8993(95)01318-0. Brain Res. 1996. PMID: 8963681

5

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain.

Glass M, Dragunow M, Faull RL. Glass M, et al. Neuroscience. 1997 Mar;77(2):299-318. doi: 10.1016/s0306-4522(96)00428-9. Neuroscience. 1997. PMID: 9472392

6

The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.

Glass M, Dragunow M, Faull RL. Glass M, et al. Neuroscience. 2000;97(3):505-19. doi: 10.1016/s0306-4522(00)00008-7. Neuroscience. 2000. PMID: 10828533

7

Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors.

Glass M, van Dellen A, Blakemore C, Hannan AJ, Faull RL. Glass M, et al. Neuroscience. 2004;123(1):207-12. doi: 10.1016/s0306-4522(03)00595-5. Neuroscience. 2004. PMID: 14667455

8

Characterization of the endocannabinoid system in early human pregnancy.

Helliwell RJ, Chamley LW, Blake-Palmer K, Mitchell MD, Wu J, Kearn CS, Glass M. Helliwell RJ, et al. Among authors: glass m. J Clin Endocrinol Metab. 2004 Oct;89(10):5168-74. doi: 10.1210/jc.2004-0388. J Clin Endocrinol Metab. 2004. PMID: 15472222

9

A novel population of progenitor cells expressing cannabinoid receptors in the subependymal layer of the adult normal and Huntington's disease human brain.

Curtis MA, Faull RL, Glass M. Curtis MA, et al. Among authors: glass m. J Chem Neuroanat. 2006 Apr;31(3):210-5. doi: 10.1016/j.jchemneu.2006.01.005. Epub 2006 Mar 14. J Chem Neuroanat. 2006. PMID: 16533591

10

Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain.

Ashton JC, Rahman RM, Nair SM, Sutherland BA, Glass M, Appleton I. Ashton JC, et al. Among authors: glass m. Neurosci Lett. 2007 Jan 29;412(2):114-7. doi: 10.1016/j.neulet.2006.10.053. Epub 2006 Nov 22. Neurosci Lett. 2007. PMID: 17123706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

601 results

Search Page

Filters